Latest Breaking News On - American academy of sciences - Page 10 : comparemela.com

Share this article Share this article CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today announced the formation of its Scientific Advisory Board (SAB). Senda s SAB is composed of leading experts across immunology, microbiology, biochemistry, and neurology, and will collaborate with Senda s leadership to support and advance the new research discipline of Intersystems Biology. This discipline focuses on how molecular connections among botanical, bacterial, and human cells coevolved over millennia define health and disease. We are thrilled to have attracted some of the brightest minds in their fields to our SAB, says Guillaume Pfefer, PhD, chief executive officer of Senda. The deep expertise of the SAB will be pivotal to the advancement of our novel approach to medicines development, rooted in an unparalleled understanding of interspecies molecular connections.

United statesDana farber cancer instituteCalifornia institute of technologyUnited kingdomUniversity of california san diegoSteve jacobsenRoger innesWendy garrettRamnik xavierLos angelesPrnewswire senda biosciencesGuillaume pfeferRandy schekmanJames rothmanSenda biosciencesWendys garrett